In the endotoxemia models, ROBO4 was shown to suppress vascular hyperpermeability by interacting with TNF receptor-associated factor 7 (TRAF7), a ubiquitin E3 ligase15. Here, ROBO4 is linked to serum lipopolysaccharide activity.